Tag: Pain
Can Cara Therapeutics buck the trend?
Cara Therapeutics (NASDAQ: CARA) recently posted its first quarter, 2019 results. The company reported a net loss of $22.0 million, or $0.56 per basic...
Zolmitriptan Derivatives and Novel Drug Delivery Systems Aim to treat Acute...
Migraine is a genetic predisposition to moderate-to-severe headaches caused due to stress, physiological factors such as lack of sleep, hunger and environmental triggers such...
We are looking for talented interns to learn and help investors find valuable companies.